Skip to main content
Log in

Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

In order to prevent postpartum hemorrhage in caesarean section under spinal anesthesia, patients routinely receive oxytocin. In this study we compared the efficacy of Methylergonovine and Oxytocin on hemodynamic stability and bleeding amount in caesarean section.

Materials and methods

In this randomised controlled trial study, 80 patients candidate for elective caesarean section under spinal anesthesia divided to two groups: 40 patients in control group received oxytocin and 40 ones in case group received methylergonovine.

Results

There was no differences between groups in Mean age, baseline hemodynamic values, after spinal anesthesia and recovery (except diastolic blood pressure min 20), time of uterine atony, dizziness; nausea and vomiting. After drug administration (oxytocin and methylergonovine), systolic blood pressure in minutes 1, 10, 15 and diastolic blood pressure in minutes 1, 3, 20 increased in case group statistically more than control group. In control group, heart rate in minutes 1, 5 increased significantly more than the other group. Mean arterial blood pressure in minutes 1, 3, 5, 10, 15 reduced significantly more than in control group. Need to vasoconstrictor drug statistically was less in case group (p < 0.0001).

Conclusion

Methylergonovine induced significantly more hemodynamic stability. Adverse effects were similar between two groups. We recommend the use of methylergonovine in patients with caesarean section under spinal anesthesia because of its hemodynamic stability and low need to vasoconstrictor drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ronald S, Gibbs DN et al (2008) Complications of delivery. Danforth's Obstetrics and Gynecology, 10th edn. Lippincott Williams & Wilkins, Philadelphia, pp 290–291

  2. Afolabi BB, Lesi FEA, Merah NA (2007) Regional versus general anaesthesia for caesarean section. Cochrane Database Syst Rev. doi: 10.1002/14651858

  3. Moertl MG, Friedrich S, Kraschl J et al (2011) Hemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomized trial. BJOG 118(11):1349–1356

    Google Scholar 

  4. Miller RD, Stoeltieng RK (2007) Basics of Anesthesia, 5th edn. Churchill Livingstone, Philadelphia, pp 280–281

    Google Scholar 

  5. Manrique Munoz S, Munar Bauza F, Frances Gonzalez S et al (2012) Update on the use of uterotonic agents. Rev Esp Anestesiol Reanim 59:91–97

    PubMed  CAS  Google Scholar 

  6. Jonsson M, Hanson U, Liddle C et al (2010) ST depression at cesarean section and the relation to oxytocin dose: a randomized Controlled trial. BJOG 117:76–83

    Article  PubMed  CAS  Google Scholar 

  7. Balki M, Dhumne S, Kasodekar S et al (2008) Ergot and oxytocin during cesarean delivery following failure to progress in labour. BJOG 115:579–840

    Article  PubMed  CAS  Google Scholar 

  8. Kumru S, Gurates B, Parmaksiz C (2005) Investigation of the usefulness of methylergonovin application in cesarean section cases. J Turkish German Gynecol Assoc. 6:42–45

    Google Scholar 

  9. Mitchell GG, Elboume DR (1993) The salford third stage trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. Online J Curr Clin Trials (doc no 83: 2305 words; 32 paragraphs)

  10. Fujimoto M, Takeuchi K, Sugimoto M et al (2006) Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor. Acta Obstet Gynecol Scand 85:1310–1314

    Article  PubMed  CAS  Google Scholar 

  11. Saito K, Haruki A, Ishikawa H et al (2007) Prospective study of intramuscular ergometrin compared with intramuscular oxytocin for prevention of postpartum hemorrhage. J Obstet Gynaecol Res 33:254–258

    Article  PubMed  CAS  Google Scholar 

  12. Kikutani T, Kikutani M, Oshima M et al (2006) Effects of methylergonovine and oxytocin on blood loss and uterine contraction during cesarean section. Masui 55(5):590–594

    PubMed  Google Scholar 

  13. Howard WF, McFadden PR, Keettel W (1964) Oxytocic drugs in fourth stage of labor. JAMA 189:411–413

    Article  PubMed  CAS  Google Scholar 

  14. Svanström MC, Biber B, Hanes M et al (2008) Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during caesarean section. Br J Anaesth 100:683–689

    Article  PubMed  Google Scholar 

  15. Singh G, Radhakrishnan G, Guleria K (2009) Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor. Int J Gynaecol Obstet 107:130–134

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahnaz Ahmadi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anvaripour, A., Shahryari, H., Ahmadi, S. et al. Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia. Arch Gynecol Obstet 287, 979–983 (2013). https://doi.org/10.1007/s00404-012-2671-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-012-2671-1

Keywords

Navigation